CRC Grand Rounds – Harlingen, TX
This live activity will cover the treatment and management of patients with refractory metastatic colorectal cancer (CRC).
This live activity will cover the treatment and management of patients with refractory metastatic colorectal cancer (CRC).
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.